Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway

Journal of Neurochemistry

Volumn 66, Issue 3, 1996, Pages 1157-1166

  Skaper, Stephen D ^a,b   Facci, Laura ^a   Romanello, Stefano ^a   Leon, Alberta ^a  

^a Researchlife ScpA   (Italy)

^b Ospedale Civile   (Italy)

Author keywords

Astrocytes; Degranulation; Inflammation; Mast cells; Myelin basic protein; Neurotoxicity; Nitric oxide; Palmitoylethanolamide

Indexed keywords

ESTRADIOL; GAMMA INTERFERON; INTERLEUKIN 1BETA; MYELIN BASIC PROTEIN; NITRIC OXIDE; PALMIDROL; PALMITIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOPATHOGENESIS; MACROGLIA; MALE; MAST CELL DEGRANULATION; MOUSE; NERVE CELL LESION; NERVE DEGENERATION; NEUROTOXICITY; NEWBORN; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030047921     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66031157.x     Document Type: Article

References (78)

1. Aloe L., Leon A., and Levi-Montalcini R. (1993) A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 39, C145-C147.
2. Apgar J. R (1994) Polymerization of actin in RBL-2H3 cells can be triggered through either the IgE receptor or the adenosine receptor but different signaling pathways are used. Mol. Biol. Cell 5, 313-322.
3. Banker G. A. and Cowan W. M. (1977) Rat hippocampal neurons in dispersed cell culture. Brain Res. 176, 397-425.
4. Beckman J. S., Beckman T. W., Chen J , Marshall P. A., and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
5. Bernstein J. A. and Lawrence I. D. (1990) The mast cell: a comprehensive updated review. Allergy Proc. 11, 209-223.
6. Bienenstock J., Tomioka M., Matsuda H., Stead R. H., Quinonez G., Simon G. T., Coughlin M. D., and Denburg J. A. (1987) The role of mast cells in inflammatory processes: evidence for nerve mast cell interactions. Int. Arch Allergy Appl. Immunol. 82, 238-243.
7. Bö L., Dawson T. M., Wesselingh S., Mörk S., Choi S., Kong P A., Hanley D., and Trapp B. D. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778-786.
8. Boje K. M. and Arora P. K. (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587, 250-256.
9. Chao C. C., Hu S., Molitor T. W., Shaskan E. G., and Peterson P. K. (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736-2741.
10. Cosi C., Suzuki H., Milani D., Facci L., Menegazzi M., Vantini G., Kanai Y., and Skaper S. D. (1994) Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J. Neurosci. Res. 39, 38-46.
11. Cross A. H., Misko T. P., Lin R. F., Hickey W. F., Trotter J. L., and Tilton R. G. (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684-2690.
12. Dawson T. M. and Snyder S. H. (1994) Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14, 5147-5159.
13. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
14. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., and Snyder S. H. (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13, 2651-2661.
15. Dawson V. L., Brahmbhatt H. P., Mong J. A., and Dawson T. M. (1994) Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 33, 1425-1430.
16. Dietsch G. N and Hinrichs D. J. (1989) The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 142, 1476-1481.
17. Dietsch G. N. and Hinrichs D. J. (1991) Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell. Immunol. 135, 541-548.
18. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.-C., and Piomelli D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
19. Dimitriadou V., Lambracht-Hall M., Reichler J., and Theoharides T. C. (1990) Histochemical and ultrastructural characteristics of brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience 39, 209-224.
20. Eikelenboom P., Zhan S.-S., vanGool W. A., and Allsop D. (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15, 447-450.
21. Endoh M., Maiese K., and Wagner J. (1994) Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651, 92-100.
22. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S. D., and Leon A. (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 92, 3376-3380.
23. Galli S. J. (1993) New concepts about the mast cell. N. Engl. J. Med. 328, 257-265.
24. Gordon J. R., Burd P. R., and Galli S. J. (1990) Mast cells as a source of multifunctional cytokines. Immunol. Today 11, 458-464.
25. Harvey G. K., Toyka K. V., and Hartung H.-P. (1994) Effects of mast cell degranulation on blood-nerve barrier permeability and nerve conduction in vivo. J. Neurol Sci. 125, 102-109.
26. Hewett S J., Csernansky C. A., and Choi D. W. (1994) Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13, 487-494.
27. Horigome K , Bullock E. D., and Johnson E. M. Jr. (1994) Effects of nerve growth factor on rat peritoneal mast cells: survival promotion and immediate-early gene induction J. Biol. Chem. 269, 2595-2702.
28. Hough L. B., Goldschmidt R. C., Glick S. D., and Padawer J. (1984) Mast cells in rat brain: characterization, localization and histamine content, in Frontiers in Histamine Research (Ganellin C. R. and Schwartz J. C., eds), pp. 131-140. Pergamon Press, New York.
29. Ibrahim M. Z. (1974) The mast cells of the mammalian central nervous system. Part I. Morphology, distribution and histochemistry. J. Neurol. Sci. 21, 431-478.
30. Johnson A. W., Land J. M., Thompson E. J., Bolanos J. P., Clark J. B., and Heales S. J R. (1995) Evidence for increased nitric oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 58, 107.
31. Johnson D. and Krenger W. (1992) Interactions of mast cells with the nervous system: recent advances. Neurochem. Res. 17, 939-951.
32. 2 can stimulate mast cell degranulation. Brain Res. 444, 195-198.
33. Kanner B. J. and Metzger H. (1983) Crosslinking of the receptors for immunoglobulin E depolarizes the plasma membrane of rat basophilic leukemia cells. Proc. Narl. Acad. Sci. USA 80, 5744-5748.
34. Kido H., Fukusen N., and Katunuma N. (1985) Chymotrypsin and trypsin-type serine proteases in mast cells: properties and functions. Arch. Biochem. Biophys. 239, 436-443.
35. Koprowski H., Zheng Y. M., Heber-Katz E., Fraser N., Rorke L., Fu Z. F., Hanlon C., and Dietzschold B. (1993) In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90, 3024-3027
36. Lambracht-Hall M., Dimitriadou V., and Theoharides T. C. (1990) Migration of mast cells in the developing rat brain. Dev Brain Res. 56, 151-159.
37. Le W. D., Engelhardt J., Xie W. J., Schneider L., Smith R. G., and Appel S. H. (1995) Experimental autoimmune nigral damage in guinea-pigs. J. Neuroimmunol. 57, 45-53.
38. Lee S. C., Dickson D. W., Liu W., and Brosnan C. F. (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ. J. Neuroimmunol. 46, 19-24.
39. Leon A., Buriani A., Dal Toso R., Fabris M., Romanello S., Aloe L., and Levi-Montalcini R. (1994a) Mast cells synthesize, store and release nerve growth factor. Proc. Natl. Acad Sci. USA 91, 3739-3743.
40. Leon A., Canella R., and Mazzari S. (1994b) N-(2-Hydroxyethyl)-hexadecanamide improves neurological deficits accompanying experimental allergic encephalomyelitis in B10/PL mice. Soc. Neurosci. Abstr. 20, 952
41. Lin R. F , Lin T. T., Tilton R. G., and Cross A. H. (1993) Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic study. J. Exp. Med. 178, 643-648.
42. Lipton S. A., Choi Y.-B., Pan Z. H., Lei S. Z., Chen H.-S. V., Sucher N. J., Loscalzo J., Singel D. J., and Stamler J. S. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
43. Manning K. A., Pienkowski T. P., and Uhlrich D. J. (1994) Histaminergic and non-histamine-immunoreactive mast cells within the cat lateral geniculate complex examined with light and electron microscopy. Neuroscience 63, 191-206.
44. Marshall J. S. and Waserman S. (1995) Mast cells and the nerves: potential interactions in the context of chronic disease. Clin. Exp. Allergy 25, 102-110.
45. Mattson M. P., Murrain M., Guthrie P. B., and Kater S. B. (1989) Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9, 3728-3740.
46. Mazzari S., Canella R., Marcolongo G., and Leon A. (1994) N-(2-Hydroxyethyl)hexadecanamide given orally reduces hyperalgesia by down-modulating mast cell activation. Soc. Neurosci. Abstr. 20, 964.
47. Merrill J. E. and Chen I. S. Y. (1991) HIV-1, macrophages, glial cells and cytokines in AIDS nervous system disease. FASEB J. 5, 2391-2397.
48. Merrill J. E., Ignarro L. J., Sherman M. P., Mclinck J., and Lane T. E. (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2141.
49. Mokhtarian F. and Griffin D. E. (1984) The role of mast cells in virus-induced inflammation in the murine central nervous system. Cell. Immunol. 86, 491-500.
50. Murphy S., Simmons M. L., Agullo L., Garcia A., Feinstein D. L., Galea E., Reis D. J., Minc-Golomb D., and Schwartz J. P. (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16, 323-328.
51. Natarajan V., Reddy P. V., Schmid P. C., and Schmid H. H. O. (1982) N-Acylation of ethanolamine phospholipids in canine myocardium. Biochim. Biophys. Acta 712, 342-355.
52. Nathan C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
53. Newson B., Dahlström A., Enerbäck L., and Ahlman H. (1983) Suggestive evidence for a direct innervation of mucosal mast cells: an electron microscopic study. Neuroscience 10, 565-570.
54. Noronha-Dutra A. A., Epperlein M. M., and Woolf N. (1993) Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing. FEBS Lett. 321, 59-62.
55. Ohno I., Tanno Y., Yamauchi K., and Takishima T. (1990) Gene expression and production of tumor necrosis factor by a rat basophilic leukaemia cell line (RBL-2H3) with IgE receptor triggering. Immunology 70, 88-93.
56. Oliver J. M., Seagrave J. C., Stump R. F., Pfeiffer J. R., and Deanin G. G. (1988) Signal transduction and cellular response in RBL-2H3 mast cells. Prog. Allergy 42, 185-245.
57. Olsson Y. (1974) Mast cells in plaques of multiple sclerosis. Acta Neurol. Scand. 50, 611-618.
58. 2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 268, 1749-1756.
59. Perlìk F., Elis J., and Raskova H. (1971) Anti-inflammatory properties of N(2-hydroxyethyl)palmitamide. Acta Physiol. Acad. Scient. Hung. 39, 395-400.
60. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
61. Purcell W. M. and Atterwill C K. (1995) Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. Neurochem. Res. 20, 521-532.
62. Radi R., Beckman J. S., Bush K. M., and Freeman B. A. (1991) Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266, 4244-4250.
63. Schmid H. H. O., Schmid P. C., and Natarajan V. (1990) N-Acylated glycerophospholipids and their derivatives. Prog. Lipld Res. 29, 1-43.
64. Selmaj K. W. and Raine C. S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-347.
65. Simmons M. L. and Murphy S. (1992) Induction of nitric oxide synthase in glial cells. J. Neurochem. 59, 897-905.
66. Simmons M. L. and Murphy S. (1993) Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur. J Neurosci. 5, 825-831.
67. Skaper S D., Facci L., Milani D., Leon A., and Toffano G. (1990) Culture and use of primary and clonal neural cells, in Methods in Neurosciences, Vol. 2 (Conn P. M., ed), pp. 17-33. Academic Press, San Diego.
68. Skaper S. D., Facci L., and Leon A. (1995) Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64, 266-276.
69. Sugiyama K. (1977) Histamine release from rat mast cells induced by Sendai virus. Nature 270, 614-615.
70. Theoharides T. C., Baloyannis S. J., and Manolidis L. S. (1991) Activated rat peritoneal mast cells can cause syngeneic brain demyelination in vitro. Int. J. Immunopath. Pharmacol. 4, 137-144.
71. Theoharides T. C., Dimitriadou V., Letourneau R., Rozniecki J. J., Vliagoftis H., and Boucher W. (1993) Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience 57, 861-871.
72. Toms R., Weiner H. L., and Johnson D. (1990) Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Immunol. 30, 169-177.
73. Trotter J. L., Clark H. B., Collins K. G., Wegeschiede C. L., and Scarpellini J. D. (1987) Myelin proteolipid protein induces demyelinating disease in mice J. Neurol. Sci. 79, 173-188.
74. Van Dam A.-M., Bauer J., Man-A-Hing W. K. H., Marquette C., Tilders F. J. H., and Berkenbosch F. (1995) Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J. Neurosci. Res. 40, 251-260.
75. Vizzard M. A., Erdman S. L., and de Groat C. (1995) Increased expression of neuronal nitric oxide synthase (NOS) in visceral neurons after nerve injury. J. Neurosci. 15, 4033-4045.
76. White M. V. (1993) Mast cell secretagogues: Histamine-releasing factors and neuropeptides, in The Mast Cell in Health and Disease (Kaliner M. A. and Metcalfe D. D., eds), pp. 109-128. Marcel Dekker, New York.
77. Wink D. A., Kasprzak K. S , Maragos C. M., Elespuru R. K., Misra M., Dunams T. M., Cebula T. A., Koch W. H., Andrews A. W., Allen J. S., and Keefer L. K. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254, 1001-1003.
78. Zhang J., Dawson V. L., Dawson T. M., and Snyder S. H. (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263, 687-689.